Total Assist
  • Home
  • Divisions
    • Doctors
      • Revalidation
      • Frameworks
      • Testimonials
      • Doctors Timesheet
      • Current Doctor Vacancies
    • Nursing
      • Revalidation
      • Nursing Timesheet
      • Current Nursing Vacancies
    • AHP | HSS
      • AHP|HSS Timesheet
      • Current AHP | HSS Vacancies
    • Education
      • Education Timesheet (Daily)
      • Education Timesheet (Hourly)
      • Current Education Vacancies
    • Care
      • Care Timesheet
      • Current Care Vacancies
    • Personnel
      • Personnel Timesheet (Daily)
      • Personnel Timesheet (Hourly)
      • Current Personnel Vacancies
    • Executive Interim
    • Current Executive Vacancies
  • Training
    • Doctors Training
    • Doctors Training Annual Update
    • Nurses Training
    • Nurses Training Annual Update
    • AHP Training
    • AHP Training Annual Update
    • Personal Training
    • Social Care Training
  • Compliance
  • Clients
  • News
  • Documents
    • AHP HSS Timesheet
    • Care Timesheet
    • Doctors Timesheet
    • Education Timesheet (Daily)
    • Education Timesheet (Hourly)
    • Nurses Timesheet
    • Personnel Timesheet (Daily)
  • About
    • Contact
    • Academy
    • Careers
    • Our Awards

Cancer Drugs Fund to face cuts

Cancer Drugs Fund to face cuts

November 13, 2014 by
6k
SHARES
ShareTweet

The list of expensive drugs covered by the prime minister’s special fund for such life-saving drugs is said to be removing some vital cancer medicines from the selection.

The price of extending a life

The price of extending a life via cancer treatments may be too costly for Cancer Drugs Funds

England’s Cancer Drugs Fund was designed by Prime Minister, David Cameron in 2010 to provide patients with access to effective treatments that were deemed too costly for hospitals to fund.

However, the fund will now introduce price-restrictions bringing 42 of the drugs to be reassessed. The issue is that the drugs must be cost effective for the NHS to make them routinely available and the Cancer Drugs Fund provided a way to give patients more expensive treatments without requiring the NHS to fund them.

One of the drugs labelled as too expensive is Kadcyla, a breast cancer therapy drug which extends life by an average of six months at the cost of £90,000 a course.

55,000 people a year used the £200m-a-year fund for treatments that extended their lives.

Cancer charities are deeply concerned by the news.

Posted in: NHS and Industry News Tagged: cancer, NHS

Copyright © 2022 Total Assist.

Hit WordPress Theme by ThemeHit